Hospira

Pfizer to acquire Hospira for $17 billion

Thursday, February 5, 2015

Pfizer has agreed to acquire Hospira, a provider of injectable drugs and infusion technologies and a global provider in biosimilars headquartered in Lake Forest, Ill., for $90 a share in cash, for a total enterprise value of approximately $17 billion.

[Read More]